See more : Legend Biotech Corporation (LEGN) Income Statement Analysis – Financial Results
Complete financial analysis of Acadia Healthcare Company, Inc. (ACHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acadia Healthcare Company, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Dätwyler Holding AG (0QNJ.L) Income Statement Analysis – Financial Results
- Questerre Energy Corporation (QEC.OL) Income Statement Analysis – Financial Results
- AVEW Holdings Inc. (AVEW) Income Statement Analysis – Financial Results
- I.C.C. International Public Company Limited (ICC.BK) Income Statement Analysis – Financial Results
- Lactose (India) Limited (LACTOSE.BO) Income Statement Analysis – Financial Results
Acadia Healthcare Company, Inc. (ACHC)
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.93B | 2.61B | 2.31B | 2.09B | 3.11B | 3.01B | 2.84B | 2.81B | 1.79B | 1.00B | 713.41M | 407.46M | 221.37M | 62.10M |
| Cost of Revenue | 2.25B | 1.49B | 1.33B | 1.24B | 1.84B | 1.78B | 1.65B | 1.66B | 1.05B | 623.83M | 445.53M | 259.14M | 167.94M | 42.36M |
| Gross Profit | 682.61M | 1.12B | 979.89M | 848.17M | 1.27B | 1.23B | 1.19B | 1.15B | 740.10M | 380.77M | 267.88M | 148.33M | 53.44M | 19.74M |
| Gross Profit Ratio | 23.31% | 42.78% | 42.34% | 40.58% | 40.78% | 40.96% | 41.80% | 40.97% | 41.24% | 37.90% | 37.55% | 36.40% | 24.14% | 31.79% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
| Other Expenses | 0.00 | 445.60M | 390.16M | 357.53M | 539.48M | -34.51M | -24.27M | -48.32M | -36.57M | -13.65M | -7.15M | -8.11M | 24.76M | -918.00K |
| Operating Expenses | 176.01M | 649.07M | 565.41M | 515.38M | 862.69M | 821.04M | 747.84M | 706.49M | 419.29M | 208.00M | 144.88M | 77.62M | 82.50M | 10.93M |
| Cost & Expenses | 2.42B | 2.14B | 1.90B | 1.76B | 2.70B | 2.60B | 2.40B | 2.37B | 1.47B | 831.84M | 590.41M | 336.75M | 250.44M | 53.29M |
| Interest Income | 0.00 | 69.76M | 76.99M | 158.11M | 187.33M | 876.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 82.13M | 69.76M | 76.99M | 158.11M | 187.09M | 185.41M | 176.01M | 181.33M | 106.74M | 48.22M | 37.25M | 29.77M | 9.19M | 738.00K |
| Depreciation & Amortization | 132.35M | 117.77M | 106.72M | 95.26M | 87.92M | 158.83M | 143.01M | 135.10M | 63.55M | 32.67M | 17.09M | 7.98M | 4.29M | 976.00K |
| EBITDA | 189.11M | 561.67M | 459.47M | 437.16M | 402.02M | 385.88M | 580.89M | 580.25M | 384.36M | 205.43M | 140.09M | 70.58M | -24.78M | 8.87M |
| EBITDA Ratio | 6.46% | 21.52% | 22.52% | 22.05% | 18.30% | 18.97% | 20.48% | 20.64% | 21.42% | 20.45% | 19.64% | 19.31% | -11.19% | 14.29% |
| Operating Income | 506.60M | 443.90M | 414.47M | 365.61M | 404.53M | 412.74M | 437.88M | 445.14M | 320.81M | 172.76M | 123.00M | 70.71M | -29.07M | 8.81M |
| Operating Income Ratio | 17.30% | 17.01% | 17.91% | 17.49% | 13.02% | 13.70% | 15.44% | 15.84% | 17.88% | 17.20% | 17.24% | 17.35% | -13.13% | 14.19% |
| Total Other Income/Expenses | -531.96M | -72.10M | -120.81M | -148.99M | -235.70M | -581.70M | -201.08M | -412.19M | -156.06M | -46.61M | -53.75M | -37.88M | -5.38M | -1.66M |
| Income Before Tax | -25.36M | 374.14M | 275.76M | 183.80M | 135.99M | -168.95M | 236.80M | 32.96M | 164.75M | 126.15M | 69.25M | 32.83M | -38.26M | 7.16M |
| Income Before Tax Ratio | -0.87% | 14.33% | 11.91% | 8.79% | 4.38% | -5.61% | 8.35% | 1.17% | 9.18% | 12.56% | 9.71% | 8.06% | -17.28% | 11.53% |
| Income Tax Expense | -9.70M | 94.11M | 67.56M | 40.61M | 25.87M | 6.53M | 37.21M | 28.78M | 46.40M | 42.92M | 25.98M | 12.33M | -5.38M | 477.00K |
| Net Income | -21.67M | 273.14M | 190.64M | 143.19M | 108.92M | -175.75M | 199.84M | 6.14M | 119.55M | 83.04M | 42.58M | 20.40M | -34.89M | 6.21M |
| Net Income Ratio | -0.74% | 10.46% | 8.24% | 6.85% | 3.51% | -5.83% | 7.05% | 0.22% | 6.66% | 8.27% | 5.97% | 5.01% | -15.76% | 10.00% |
| EPS | -0.24 | 3.05 | 2.30 | 1.63 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.51 | 0.85 | 0.53 | -1.86 | 0.35 |
| EPS Diluted | -0.24 | 2.98 | 2.25 | 1.62 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.50 | 0.85 | 0.53 | -1.86 | 0.35 |
| Weighted Avg Shares Out | 90.95M | 89.68M | 88.77M | 87.88M | 87.61M | 87.29M | 86.95M | 85.70M | 68.09M | 55.06M | 50.00M | 38.48M | 18.76M | 17.63M |
| Weighted Avg Shares Out (Dil) | 90.95M | 91.56M | 90.79M | 88.60M | 87.82M | 87.29M | 87.06M | 85.97M | 68.39M | 55.33M | 50.26M | 38.70M | 18.76M | 17.63M |
The Schall Law Firm Invites Stockholder Participation In A Securities Fraud Case Against Acadia Healthcare Company Inc
LOS ANGELES, CA / ACCESSWIRE / November 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of...
Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of the December 16, 2024 - ACHC
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi Reminds Acadia Healthcare Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 16, 2024 - ACHC
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their Options
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Acadia Healthcare Company, Inc. - ACHC
NEW YORK, NY / ACCESSWIRE / November 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at...
ACHC STOCK NEWS: Acadia Healthcare Stock Plummeted 16% - Contact BFA Law about its Class Action Lawsuit if You Suffered Losses (Nasdaq:ACHC)
Acadia Healthcare Company, Inc. investors that lost money on their investment are encouraged to contact BFA Law before December 16, 2024 legal deadline.
ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Acadia Healthcare Company, Inc. to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / November 22, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company")...
ACADIA HEALTHCARE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
NEW ORLEANS, LA / ACCESSWIRE / November 21, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 16, 2024 to file lead...
ROSEN, A TOP-RANKED LAW FIRM, Encourages Acadia Healthcare Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ACHC
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the...
ACHC INVESTOR NOTICE: Acadia Healthcare Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) publicly traded securities between February 28, 2020 and September 26,...
Acadia Healthcare Company, Inc. Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / November 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of...
Source: https://incomestatements.info
Category: Stock Reports